Globe Newswire
Investeringsforeningen ValueInvest Danmark indkalder til ekstraordinær generalforsamling, der afholdes mandag den 7. september 2026 kl. 9.00. Indkaldelsen med sted, dagsorden samt fuldstændige forslag er vedhæftet.
Eventuelle henvendelser vedrørende denne meddelelse bedes rettet til undertegnede på tlf. 38 14 66 00.
Med venlig hilsenInvest Administration A/S
Niels Erik EberhardDirektør
Attachment
QINGDAO, China, Aug. 14, 2026 (GLOBE NEWSWIRE) -- On the evening of July 17, the historic city venue of the 36th Qingdao International Beer Festival, hosted by the Qingdao Municipal People's Government, was launched. Carrying forward the iconic theme "Qingdao Toasts with the World," the 30-day festival runs through Aug. 15 across three main venues - West Coast, Laoshan, and the Historic City. Spanning both the Shinan and Shibei districts, the historic city venue links... (continue reading...)
QINGDAO, China, Aug. 14, 2026 (GLOBE NEWSWIRE) -- On the evening of July 17, the historic city venue of the 36th Qingdao International Beer Festival, hosted by the Qingdao Municipal People's Government, was launched. Carrying forward the iconic theme "Qingdao Toasts with the World," the 30-day festival runs through Aug. 15 across three main venues - West Coast, Laoshan, and the Historic City. Spanning both the Shinan and Shibei districts, the historic city venue links... (continue reading...)
Bestyrelsen for Investeringsforeningen ValueInvest Danmark har i dag den 14. august 2026 godkendt foreningens halvårsrapport for 2026. Rapporten, der ikke er revideret, er vedhæftet denne meddelelse.
Halvårsrapporten kan endvidere downloades fra foreningens hjemmeside https://valueinvestdanmark.dk/ samt rekvireres ved henvendelse til Invest Administration A/S, Badstuestræde 20, 1209 København K, tlf. 3814 6600.
Med venlig hilsen
Bestyrelsenfor Investeringsforeningen... (continue reading...)
ProVen Growth and Income VCT plc Director/PDMR Shareholding14 August 2026ProVen Growth and Income VCT plc (the “Company”) hereby announces that on 14 August 2026, certain directors, and their closely associated persons, purchased ordinary shares of 1.6187 pence each in the Company. This notification relates to transactions notified in accordance with the Market Abuse Regulation, further details of which are set out below.
1Details of the person discharging managerial... (continue reading...)
More Globe Newswire
View Older Stories-
Outlook Therapeutics Reports Third Quarter Fiscal Year 2026 Financial Results and Provides Business Update Highlighting FDA Approval of LYTENAVA™
-
ProVen Growth and Income VCT plc: Issue of Equity
-
ProVen VCT plc: Director/PDMR Shareholding
-
ProVen VCT plc: Issue of Equity
-
Saputo Enters Agreement to Sell its United Kingdom Operations
-
A free, AI-powered youth entrepreneurship platform, “Dear Dreamer,” launches, built at the Martin Trust Center for MIT Entrepreneurship and made possible through a gift by the Frank & Eileen F
-
A free, AI-powered youth entrepreneurship platform, “Dear Dreamer,” launches, built at the Martin Trust Center for MIT Entrepreneurship and made possible through a gift by the Frank & Eileen Found
-
Koryx Copper Provides Further Drill Results for the Haib Copper Project in Southern Namibia
-
Almaden Provides Update on Arbitration Process with Mexico
-
Prospectiva Resources Begins Trading on the TSX Venture Exchange
-
J & J SNACK FOODS CORP. ANNOUNCES QUARTERLY CASH DIVIDEND
-
Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business Update
-
Kanen Wealth Management calls for sale of Zevia to Maximize shareholder value
-
Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
-
Aurora Mobile and Exabytes Sign Three-Year Strategic MoU to Bring AI-Powered Customer Engagement to Businesses Across Southeast Asia
-
J & J SNACK FOODS CORP. ANNOUNCES QUARTERLY CASH DIVIDEND
-
Medicenna Therapeutics Reports First Quarter Fiscal 2027 Financial Results and Announces Oral Presentations at Upcoming Conferences
-
Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial of FT819 for the Treatment of Lupus Nephritis
-
Adlai Nortye Ltd. Reports Unaudited First Half 2026 Financial Results and Highlights Recent Operational Progress
-
Teamshares Reports 2Q 2026 Results and Reaffirms 2026 Outlook
-
JOYY to Announce Second Quarter 2026 Financial Results on August 25, 2026
-
L4VA and Toto Finance Launch Tokenized Silver Vault
-
Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal Phase 2 Clinical Trial
-
PowerCompute Reports Second Quarter 2026 Financial Results
-
Beyond Meat Announces Effectiveness of 1-for-30 Reverse Stock Split
-
Pro Kapital Council approved Consolidated Interim Report for II Quarter and 6 Months of 2026 (Unaudited)
-
Copenhagen Infrastructure Partners’ Growth Markets Fund II closes at USD 3 billion
-
SCHMID Announces Investor Conference Call and Webcast
-
Brookfield Business Corporation Announces Renewal of Normal Course Issuer Bid
-
Rein Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
-
Directed offering of shares of EfTEN Real Estate Fund AS
-
LyondellBasell announces quarterly dividend
-
UTStarcom Reports Unaudited Financial Results for First Half of 2026
-
ALK’s tree pollen and house dust mite tablets now recommended by NICE for paediatric treatment in the UK health system
-
Diginex and Resulticks Sign Amended Definitive Agreement to Create a Global AI-Powered Group Spanning Customer Engagement and Trusted Sustainability Data
-
MEXC's August 2026 Proof of Reserves Confirms User Assets Fully Backed as Reserve Ratios Remain Above 100%
-
MEXC's August 2026 Proof of Reserves Confirms User Assets Fully Backed as Reserve Ratios Remain Above 100%
-
Super Hi to Report Second Quarter 2026 Financial Results on Wednesday, August 26, 2026
-
Kodiak AI Receives DMV Permit to Test Autonomous Trucks in California
-
Tulikivi Corporation Half Year Financial Report 1–6/2026: Strategic projects progressed despite uncertainty in the fireplace market
-
Notification of managers and closely related parties' transactions with A.P. Møller - Mærsk A/S shares
-
Form 8.5 (EPT/RI)-Gooch & Housego plc
-
Form 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc
-
Form 8.5 (EPT/RI)-Gamma Communications Plc
-
Form 8.5 (EPT/RI) - Kore Potash Plc
-
Form 8.5 (EPT/RI) - Pharos Energy Plc
-
Director/PDMR Shareholding
-
Form 8.5 (EPT/RI) - CAB Payments Holdings Plc
-
Form-8.3 GOOCH & HOUSEGO PLC - 13 08 2026 - (CGWL)
-
Form 8.5 (EPT/RI) - Alternative Income REIT plc
